| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 07/30/2003 | CN1432357A Fever allaying prepn containing xylitol |
| 07/30/2003 | CN1116291C Substituted tetracyclic tetrahydrofuran derivatives |
| 07/30/2003 | CN1116288C Urea derivatives as inhibitors of inosine-5'-phospho-dehydrogenase |
| 07/30/2003 | CN1116287C Diphenyl heterocycles as potassium channel modulators |
| 07/30/2003 | CN1116286C 4-anilinoquinazoline derivatives |
| 07/30/2003 | CN1116046C Injecta for curing primary varix of lower limb |
| 07/29/2003 | US6600072 Substituted 1-naphthoylguanidines, process for their preparation, their use as a medicament or diagnostic , and medicament containing them |
| 07/29/2003 | US6600059 Protecting cells from injury due to intrinsic membrane lysis, oxidation and/or invasion by destructive agents. Even more particularly, the present invention provides compositions and methods for treating or prophylactically inhibiting |
| 07/29/2003 | US6600047 Substantially free from amlodipine aspartate side products, by reacting amlodipine or an acid addition salt thereof with excess maleic acid under acidic environment |
| 07/29/2003 | US6600043 Carboxylic acid derivatives, their preparation and use |
| 07/29/2003 | US6600038 Carbamoyl tetrahydropyridine derivatives |
| 07/29/2003 | US6600037 4,5-disubstituted-2-aminopyrimidines |
| 07/29/2003 | US6600036 Treating diseases of the central nervous system. |
| 07/29/2003 | US6599943 Preventive treatment, related to the radical generating nature of the xanthine dehydrogenase/xanthine oxidase |
| 07/29/2003 | US6599942 Method of lowering LDL cholesterol and Lipoprotein a levels in mammals using such compounds |
| 07/29/2003 | US6599935 2-phenyl-1,3-propanediol dicarbamate derivatives used as antiepileptic and antiischemic agents |
| 07/29/2003 | US6599932 Highly selective in killing tumor cells but not normal cells |
| 07/29/2003 | US6599928 Administering agent that inhibits the contraction or migration of smooth muscle cells; sustained dosage; biological stents |
| 07/29/2003 | US6599925 Cardiovascular disorders; anticancer agents |
| 07/29/2003 | US6599918 Substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benzopyrans |
| 07/29/2003 | US6599917 A squalene-synthesizing enzyme inhibitor, a cholesterol biosynthesis inhibitor and a triglyceride biosynthesis inhibitor |
| 07/29/2003 | US6599910 Substituted triazole compounds |
| 07/29/2003 | US6599901 Pyridone substituted benzothiazole derivatives |
| 07/29/2003 | US6599896 Use of tianeptine in the production of medicaments to treat neurodegenerative pathologies |
| 07/29/2003 | US6599881 Treating a thrombotic disorder that is not the result of an endotoxin-initiated coagulation cascade in a subject comprising administration of a bactericidal/ permeability-increasing protein (BPI) protein |
| 07/29/2003 | US6599875 IL-6 antagonist peptides |
| 07/29/2003 | US6599727 Human poly (ADP-ribose) polymerase 2 materials and methods |
| 07/29/2003 | US6599706 Recombinant PR-3 and assays employing the same |
| 07/29/2003 | US6599499 Uses of diterpenoid triepoxides as an anti-proliferative agent |
| 07/29/2003 | CA2244621C 4-aminopyrrole (3,2-d) pyrimidines as neuropeptide y receptor antagonists |
| 07/29/2003 | CA2210444C Keratinocyte growth factor-2 |
| 07/29/2003 | CA2185036C Use of a non photosynthetic filamentous bacteria extract and composition containing the same |
| 07/29/2003 | CA2180119C The composition containing snapping turtle and tortoise, the preparation and the use thereof |
| 07/29/2003 | CA2056065C Preparation of 3-alkylated indoles |
| 07/24/2003 | WO2003060475A2 Melanin concentrating hormone receptor ligands: substituted 2-(4-benzyl-piperazin-1-ylmethyl)- and 2-(4-benzyl-diazepan-1-ylmethyl)-1h-benzoimidazole analogues |
| 07/24/2003 | WO2003060149A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 07/24/2003 | WO2003060085A2 Mammalian neural stem cells, compositions and uses thereof |
| 07/24/2003 | WO2003060082A2 Use of modified pyrimidine compounds to promote stem cell migration and proliferation |
| 07/24/2003 | WO2003060077A2 Endothelial stem cells, populations, methods of isolation and use thereof |
| 07/24/2003 | WO2003060076A2 Povidone-containing carriers for polypeptide growth factors |
| 07/24/2003 | WO2003059948A1 Dilated cardiomyopathy associated gene-2 (dcmag-2): a cytoplasmatic inducer of sarcomeric remodeling in cardiomyocytes |
| 07/24/2003 | WO2003059939A1 Solid salts benzazepine compounds and their use in the preparation of pharmaceuticals compounds |
| 07/24/2003 | WO2003059924A1 Novel binding epitopes for helicobacter pylori and use thereof |
| 07/24/2003 | WO2003059921A1 Mmp inhibitors |
| 07/24/2003 | WO2003059913A1 Roh-kinase inhibitors |
| 07/24/2003 | WO2003059912A1 Oxothieno (3, 2-b) pyridinecarboxamides as antiviral agents |
| 07/24/2003 | WO2003059911A2 4-OXO-4, 7-DIHYDROFURO[2,3-b]PYRIDINE-5-CARBOXAMIDE ANTIVIRAL AGENTS |
| 07/24/2003 | WO2003059900A1 Coumarin derivatives, process for their production and use thereof |
| 07/24/2003 | WO2003059899A1 Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them and uses thereof |
| 07/24/2003 | WO2003059893A1 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases |
| 07/24/2003 | WO2003059892A1 Substituted alkyl uracils and the use thereof |
| 07/24/2003 | WO2003059891A1 Substituted pyridazinones as inhibitors of p38 |
| 07/24/2003 | WO2003059886A1 Acyl sulfonamide derivative |
| 07/24/2003 | WO2003059884A1 Modulators of lxr |
| 07/24/2003 | WO2003059880A1 Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these |
| 07/24/2003 | WO2003059875A2 DERIVATIVES OF α-PHENYLTHIOCARBOXYLIC AND α-PHENYLOXY-CARBOXYLIC ACIDS USEFUL FOR THE TREATMENT OF DISEASES RESPONDING TO PPARα ACTIVATION |
| 07/24/2003 | WO2003059874A2 Aromatic thioether liver x-receptor modulators |
| 07/24/2003 | WO2003059873A1 Potassium channel modulators |
| 07/24/2003 | WO2003059871A1 N-alkylsulfonyl-substituted amide derivatives |
| 07/24/2003 | WO2003059864A2 Pheny(alkyl)carboxylic acid derivatives and dionic phenylalkylheterocyclic derivatives and their use as medicines with serum glucose and/or serum lipid lowering activity |
| 07/24/2003 | WO2003059855A1 Synthesis of combretastatin a-2 prodrugs |
| 07/24/2003 | WO2003059807A2 Crystalline solids of carvedilol and processes for their preparation |
| 07/24/2003 | WO2003059436A2 Compositions and methods for promoting myocardial and peripheral angiogenesis |
| 07/24/2003 | WO2003059388A1 Formulations of quinapril and related ace inhibitors |
| 07/24/2003 | WO2003059375A1 Complex therapy for tissue regeneration |
| 07/24/2003 | WO2003059372A2 Combined use of a glp-1 compound and a modulator of diabetic late complications |
| 07/24/2003 | WO2003059359A1 D-tagatose as an anti-biofilm agent |
| 07/24/2003 | WO2003059348A1 2-oxo-benzimidazolyl substituted ethanolamine derivatives and their use as beta3 agonists |
| 07/24/2003 | WO2003059345A1 Pharmaceutical compositions comprising valsartan and nep inhibitors |
| 07/24/2003 | WO2003059341A1 1,3-disubstituted and 1,3,3,-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications |
| 07/24/2003 | WO2003059326A1 Pharmaceutical composition having thrombolytic, anti-inflammatory and cytoprotective properties |
| 07/24/2003 | WO2003059323A2 Stable salts of o-acetylsalicylic acid containing basic amino acids ii |
| 07/24/2003 | WO2003059294A2 Combinations of peroxisome proliferator-activated receptor-alpha agonists and cyclooxygenase-2 selective inhibitors and therapeutic uses therefor |
| 07/24/2003 | WO2003059293A2 17-hydroxy-4-aza-androstan-3-ones as androgen receptor modulators |
| 07/24/2003 | WO2003059289A2 Melanin concentrating hormone receptor ligands: substituted benzoimidazole analogues |
| 07/24/2003 | WO2003059288A2 Liposome drug delivery of polycyclic, aromatic, antioxidant or anti-inflammatory compounds |
| 07/24/2003 | WO2003059276A2 Novel mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof |
| 07/24/2003 | WO2003059274A2 Vitamin formulation for cardiovascular health |
| 07/24/2003 | WO2003059269A2 Acridone inhibitors of impdh enzyme |
| 07/24/2003 | WO2003059266A2 Post-conditioning for the reduction of ischemic-reperfusion injury in the heart and other organs |
| 07/24/2003 | WO2003059258A2 Compositions and methods for treating heart failure |
| 07/24/2003 | WO2003059253A2 Compositions and methods for altering glucose production |
| 07/24/2003 | WO2003047577A3 Pharmaceutical compositions comprising dihydropyridinone compounds and an immunoregulatory or an antiinflammatory agent and their uses |
| 07/24/2003 | WO2003045999A3 Human vanilloid receptor protein and polynucleotide sequence encoding same |
| 07/24/2003 | WO2003032918A3 Treatment of infectious disease using interleukin-1 beta converting enzyme (ice)/ced-3 family inhibitors |
| 07/24/2003 | WO2003032910A3 Carbinols for the treatment of neuropathic dysfunction |
| 07/24/2003 | WO2003011309A3 Pharmaceutical composition for treating hypercholesterolaemia |
| 07/24/2003 | WO2003006645A3 Method and composition for inhibiting heparanase activity |
| 07/24/2003 | WO2002072104A3 Antihypertensive agent and cholesterol absorption inhibitor combination therapy |
| 07/24/2003 | WO2002060942A3 Protein modification and maintenance molecules |
| 07/24/2003 | WO2002049669A3 Electrically responsive promoter system |
| 07/24/2003 | WO2002042272A3 Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade |
| 07/24/2003 | US20030140360 Transgenic mammals and reagents for improving long-term memory |
| 07/24/2003 | US20030140358 Transgenic mammal coding serine protease inhibitor which is expressed in mammary gland tissue and products for treating immunosuppression disorders and angioedema |
| 07/24/2003 | US20030139687 Noninvasive measurement of chemical substances |
| 07/24/2003 | US20030139616 Alcohol extraction to remove intracellular free cholesterol |
| 07/24/2003 | US20030139607 Antiarrhythmic agents, treating cardiovascular disorders, infarct prophylaxis, angina pectoris, shock, stroke, transplant organ surgery |
| 07/24/2003 | US20030139597 Novel Cyclic hydroxamic acid as metalloproteinase inhibitors |
| 07/24/2003 | US20030139590 Comprises nucleotide sequences coding orphan receptor 25 for detecting modulators of platelet activating factor (PAF) activity; antiinflammatory agents; gene/translation inhibition; drug screening |
| 07/24/2003 | US20030139585 Oligonucleotide derivatives which are at least partly double-stranded and which have a 2'5'-linked oligonucleotide residue on at least one 3' end; use in formulating pharmaceutical for tumor therapy, infectious diseases |